Good afternoon, and welcome to the NVE Corporation Conference Call for the quarter ended September 30, 2025. I'm Dan Baker, NVE's President and CEO. I'm joined by Daniel Nelson, our Principal Financial Officer, and Pete Eames, Vice President of Advanced Technology. This call is being webcast live by YouTube and Amazon Chime and being recorded. A replay will be available through our website, nve.com, and our YouTube channel, youtube.com/nvecorporation. After my opening comments, Daniel Nelson will present our financial results. Pete will cover new products in R&D, I'll cover the business, and then we'll open the call to questions. We issued our press release with financial results and filed our quarterly report on Form 10-Q in the past hour following the close of market. Links to the press release and 10-Q are available through our website, the SEC's website, and X, formerly known as Twitter. Please refer to the safe harbor statement on your screen. Comments we may make that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties, including, among others, such factors as uncertainties related to the economic environments in the industries we serve, risks and uncertainties related to future sales and revenue, and risks and uncertainties related to tariffs, customs duties, and other trade barriers as well as the risk factors listed from time to time in our filings with the SEC, including our annual report on Form 10-K for the year ended March 31, 2025. Actual results could differ materially from the information provided, and we undertake no obligation to update forward-looking statements we may make. We're pleased to report a 4% sequential increase in revenue driven by strong increases in distributor and nondefense sales despite an expected decrease in defense sales. Daniel Nelson will cover details of the financials. Daniel?

Revenue increased 4% quarter-over-quarter sequentially and decreased 6% year-over-year. The year-over-year decrease was due to a 68% decrease in contract R&D revenue, partially offset by a 1% increase in product sales. Contract R&D was 3% of revenue. The year-over-year increase in product sales was due to a 21% increase in nondefense sales, partially offset by a 64% decrease in defense sales which can be volatile because of defense procurement cycles. Defense products sales were 8% of revenue in the past quarter. Contract R&D is primarily defense or government related and those revenues can also be uneven. Our defense business is primarily anti-tamper products that protect U.S. technology. It's important to our country and is a profitable business, although it's not part of our growth strategy. The defense business has been steadily recovering this fiscal year and as expected, defense industries sales increased sequentially in the past quarter. Distributor sales also increased nicely both sequentially and year-over-year. Gross margin decreased to 78% from 86% in the prior year quarter due to a less profitable product mix and strong distributor sales, which tend to have lower margins than direct sales. Total expenses decreased 7% for the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025 due to a 3% increase in R&D expense and a 23% decrease in SG&A. The increase in R&D was due to increased new product development. The decrease in SG&A was primarily due to the timing of sales and marketing activities and reassignment of some SG&A resources to manufacturing and new product development. Our tax rate increased to 20% for the second quarter of fiscal 2026 compared to 17% for the second quarter of fiscal 2025 primarily due to the noncash impact of tax law changes on certain tax deductions this fiscal year. We currently expect a full year tax rate of between 16% and 17% this fiscal year because we expect advanced manufacturing investment tax credits of between $700,000 and $1 million to offset the effect of other tax law changes. The advanced manufacturing investment tax credit was extended in a tax bill enacted in July and increases from 25% to 30% in calendar 2026. We currently expect our effective tax rate next fiscal year to also be approximately 16% to 17%. More importantly, the tax law changes will reduce our cash taxes by approximately $1 million over 3 quarters, starting this quarter, the December quarter by allowing us to accelerate the deduction of previously unamortized R&D expenses. After taxes, net income for the second quarter of fiscal 2026 was $3.31 million or $0.68 per diluted share compared to $4.03 million or $0.83 per share for the prior year quarter. The decrease in net income for the quarter was primarily due to decreased revenue, lower margins and a higher tax rate compared to a year ago, partially offset by decreased expenses. Our profitability metrics remained strong. Operating margin was 58%, pretax margin was 65% and net margin was 52%. For the first 6 months of fiscal 2026, total revenue was $12.5 million, and net income was $6.89 million or $1.42 per diluted share adding in approximately $159,000 in unrealized gain on our marketable securities for the fiscal year. Comprehensive income for the first half was $7.05 million. Turning to cash flow items. Cash flow from operations was $7.98 million in the first 6 months of the fiscal year. Accounts receivable decreased $1.1 million, primarily due to the timing of customer payments. Prepaid expenses and other assets increased by $730,000 primarily due to an increase in accrued bond interest and a decrease in federal and state taxes due. The decrease in taxes due was because we deducted previously unamortized research and development expenses in the past quarter as permitted under the federal budget reconciliation bill enacted July 4, 2025. Accrued payroll and other current liabilities decreased $286,000, primarily due to the payments of federal and state taxes balance due as of March 31, 2025. Fixed asset purchases were $1.13 million for the first half of the fiscal year. Most of that was for a cluster of production equipment, which arrived in July. We successfully installed the equipment in the past quarter and hope to complete deployment by the end of this fiscal year. We currently expect to spend an additional $1 million to $1.5 million on fixed assets in the last 6 months of the fiscal year to complete our production expansion. Pete Eames will discuss that equipment shortly. Now I'll turn the call over to Pete Eames, our Vice President of Advanced Technology to talk about our plans for the new equipment and to cover new products and R&D. Pete?

Thanks, Daniel. I will cover new equipment and R&D. New equipment in the past year will increase our capacity, increase our capabilities and allow us to do wafer-level chip scale packaging in-house. As Daniel said, we completed installation of a new equipment cluster in the past quarter and an expanded production area on the east end of our building. We've begun developing advanced spintronic processes on the new equipment and wafer-level chip scale packaging makes our parts smaller and more precise. Our R&D strategy is to make the world's best electronics for high-value markets such as medical devices, electric and autonomous vehicles, advanced factory and humanoid robotics in highly automated fourth wave factories using artificial intelligence of things. Executing on that strategy, we launched 3 new products in the past quarter: a rotation sensor for applications such as network utility meters and robotics, a new type of data coupler for motor control and energy conversion, and a new wafer-level chip scale voltage regulator for ultra miniature and ultra robust power conversion in harsh environments. There are demonstrations of the new products on our website and on our YouTube channel. Going forward, with the ingenuity of our engineers and scientists, the new equipment will continue to accelerate product development and fuel growth. Now I'll turn it back over to Dan.

Thanks, Pete. I'll cover sales and marketing in our annual meeting. We exhibited at the medical design and manufacturing trade show the past 2 days in Minneapolis, part of the advanced manufacturing event. Minnesota is a health care industry hub and medical devices are an important market for us. We have a compelling benefit proposition for medical devices with small size, low power, and superb reliability. At the show, we highlighted new wafer-level chip scale parts for miniaturization of implantable medical devices and surgical robots, high-sensitivity sensors for medical device navigation, our best-in-class electrical isolators to ensure the safety of medical instruments, and nano power sensors for battery-powered medical devices. We gave away working sensor circuit boards with permanently connected batteries at the show to demonstrate ultra-low power performance. It was a popular promotion. We've been following up on some good leads from the show, and we believe our investments in trade shows will pay off in future sales. We held our Annual Shareholders Meeting in the past quarter here at NVE. Proxy advisory firms recommend in-person annual meetings for good governance. All of our directors and officers attended along with our auditors. We had a chance to meet shareholders, answer questions, do live demos, and provide tours. Shareholders had a chance to see our expanded production area and our new equipment. We set up a compressor and a compressed air tank to demonstrate pneumatic cylinder sensors. Pneumatic cylinders are the muscles of many robots, and our sensors are their eyes. Visitors could try out our new wafer level chip scale sensors and advanced proximity sensors for advanced robotics. In the formal meeting, each director was reelected, named executive officer compensation was approved, and the selection of our independent registered public accounting firm was ratified. We filed the final vote counts in a current report on Form 8-K. There's a replay of the annual meeting and demonstrations on our website and YouTube channel. Now we'd like to open the call for questions.

Hello. Am I on?

You are.

Okay. Well, I have a quick question. It's great that you're selling out this new equipment. Are we — should we expect to see growth in revenues for this new equipment? Or is it just growth in capabilities?

No. Part of our goal, as Pete said in the prepared remarks, is to use the new equipment to develop advanced products and to fuel our future growth. So it's both to increase our capabilities and to develop new products.

Right. And when should we see that future growth?

Well, our goal is always to grow. And in our core market, we grew. We had strong growth in the past quarter. So we're starting to see the results of our R&D and our expansion plans already.

So you're referring to the sequential growth and also to the nonmilitary growth. Is that correct?

Exactly.

Okay. Okay. All right, and the chip level scale packaging, when should — when would that ramp up?

Well, we've been sampling the products for several quarters now. We have customer interest, and we're continuing to expand that product line. So we expect it to be a significant growth driver going forward.

Going forward, meaning as soon as this current quarter?

Yes, conceivably. In certain industrial markets, that's certainly possible. Our goal is to make a design-in process as fast as possible. In the medical markets, which is one of our core markets, sometimes the development cycle can be a long time because of regulatory issues. But in the industrial markets, our goal is to get design wins.

Can you tell us again what the advantages of chip level scale packaging be?

So the advantages are that the parts are smaller, more precise, they're more precise because they're smaller and so they have more spatial specificity. And then the other business advantage is that we can do that in-house. So we're less susceptible to supply chain risks and, of course, the costs associated with those, especially in an environment with uncertain tariffs.

Okay. This is all great to hear. This is all for me, and I apologize, could you remind me how to get off the call, how to mute my line while remaining on the call?

This is all great to hear. This is all for me, and I apologize, could you remind me how to get off the call, how to mute my line while remaining on the call?

Dan, it's Jeff Bernstein.

Hi, Jeff.

A couple of questions for you. I'm curious is wafer scale packaging now allowing you to have a fully domestic supply chain for those parts? And part 2, do you have a fully domestic supply chain for any of your other parts?

We have — I think it's fair to say a mostly domestic supply chain. We do buy materials from overseas as most companies do, of course, but we are uniquely well-situated in the tariff environment because we're quite self-sufficient. We do the key operations, including front end, which is wafer deposition and back end, which is test. And with the addition of wafer-level chip scale that will eliminate — that will bring in-house one of the key elements of the supply chain, which is packaging our parts. Most of our traditional parts are packaged overseas as are most semiconductors. But we are uniquely independent.

Got you. But okay. So — but it does sound like these new parts will make you 100% domestic?

Well, I wouldn't want to quite say 100%, Jeff, just because there are other materials and chemicals and things that we're relying on supply — but in terms of...

I really mean just — yes, fabrication takes place in the...

Right. Yes. That's true.

Okay. Okay. That's great. And then I was curious, can you just remind us, you did mention a couple of things about the focus that you guys provide in medical devices. Can you remind us on hearing aids? I know Starkey, I think, now has a brand-new, very high-end hearing aid product coming out. I would guess that usually this stuff happens in cycles and that probably Sonova is probably doing the same thing. But just remind us what you do in that market and then also in the medical device market in terms of the part functions that you offer?

So in general, we enable communications between the device and the outside world for uploading and downloading data, and the uniqueness of our type of solution is that it's very secure and difficult to hack. We probably shouldn't get into the specifics of what our customers do just because it's confidential to them. But the advantages that we offer that are important in those markets are that our parts are small. They are very low power because these are battery devices, battery-powered devices, and they're extremely reliable, which for medical device is, of course, critical.

Got you. I seem to remember that in hearing aids is really sort of detecting if somebody is holding a handset by their ear. Is that still kind of the main thing?

That's been reported, yes.

Got you. Okay. And then in cardiac rhythm management, where your customer Abbott has this sort of revolutionary or pacemakers. And now they have them for dual implantation. So 2 at a time or in each chamber of the heart. Is that a product location thing? Or is it a communication? Or what is it exactly in those kinds of CRM applications?

Jeff, this is Pete Eames. I can try to answer that question for you. Of course, we can't get into the specifics, but yes, we provide some unique capabilities for implanted medical devices in general. So we're small size and low power, as Dan mentioned, and that's ideal for small applications and battery-powered applications, among others.

Okay. That's all I'm going to get, I guess. All right. You mentioned the isolator business and some new products. There's a significant shift in data centers to 800-volt DC. We've discussed before that your products are compatible with some of the silicon carbide high-power density and high switching speed ICs that are emerging. Are your solutions applicable in these data center applications? Can you elaborate a bit on that?

Yes. We have some of the highest isolation voltage ratings in the industry, Jeff. And the voltages that you mentioned for data centers are well within our sweet spot for those applications. So it is a good application for NVE, and it's something that we're excited about.

And it seems like there's probably not a huge amount of touch points in that industry to have to go after. You don't have the same problem of every engineer having their analog devices or Texas Instruments sort of website on their browser. How do you guys try to go to market to try and get into that arena?

You're right, Jeff. It's a concentrated market, which is well suited to us because we can reach those folks. And we reach them through direct outreach, through distributors that specialize in those types of energy conversion markets, and through demonstrating our capabilities through our various marketing collaterals such as newsletters, application notes and videos that show the unique capabilities that we have to convert energy extremely efficiently using those new wideband gap devices that you mentioned.

Got you. And I would guess you could say the same thing for the eVTOL market. There's not a ton of players there. Is that basically the same story there? And have you actually gotten any design wins in that market?

So you're right, that's a concentrated market as well. We target the Tier 1 and Tier 2 suppliers. So those are the companies that make modules that go into the cars. So we're not targeting the nameplate car manufacturers because they are buying these sorts of modules generally from other companies. So we target those customers. Again, we use the marketing means that I mentioned, direct outreach, distributors — face-to-face distributors, and bulletins and newsletters. We can point to a number of automotive adjacent market design wins. Automotive adjacent, I mean by that charging stations, trucks, and trains. Cars have a unique qualification process, and we've engaged with companies to go through that process. So we're optimistic that we can add considerable value to next-generation cars, hybrid electric vehicles, and autonomous vehicles.

Got you. Got you. And I'm sorry, I was meaning to ask about eVTOLs, the vertical takeoff and landing electric vehicles, which is sort of a very small opportunity of players there.

We have significant advantages in that type of power control. Obviously, there's a premium on efficiency in that market on small size and on reliability. So those are the types of markets that we feel have the high value added that makes them good markets for us.

Got you. Okay. And then I take it, Dan, that you are not a gamer, but I was really interested in that TDK press release about TMR sensors for game controllers to give the gamer an advantage over other players. And I actually think that's a really premium market because there are people who will pay anything to have the best NVIDIA chips for their systems and these kinds of game controllers. So I don't know if that's a market that you guys are able to go after, but...

I can jump in here again, Jeff. We have looked closely at consumer electronics and in this case, gaming markets. We found the devices much less demanding than our target markets and robotics, industrial Internet of Things, and medical. We even did a couple of demos last year, you might have seen showing the precision and speed of our sensors in comparison to some alternatives. Gamers look for millisecond responses. We demonstrated microsecond responses, thousands of times faster in our promotional video, so you can find all this on our YouTube site.

Got you. Okay. All right. That's great. And then I'm sorry, I think I got on a minute or 2 late. Did you say anything about the PUF market in the quarter? Did it recover? Or did it not recover in this quarter?

Yes. So the PUF market, so that's — for us, that's a physical unclonable function. That is something that we work actively in. Many of our anti-tamper products use PUF technology. We're currently selling these into military systems, and there's many potential commercial applications as well. I think we alluded to the financials on that earlier, and I think Daniel was clear that there's quite a bit of volatility in those sales.

Got you. And so were they — did they recover in this quarter from the prior quarter? Or were they still down?

So we talked about sequential growth, but not year-over-year.

Got you. Okay...

And as we've said, that's not — well, and as you know, that's not one of the markets. It's an important market to us, and we're proud to be a part of that. But — it's not really a key part of our growth strategy. We were very pleased to see the nondefense sales grow so strongly.

Got you. And lastly, Dan, we talked last quarter about your application of very high sensitivity sensors to allow people to get rid of rare earth metal magnets. And I think you guys had said that you had some design wins. I'm just wondering kind of how long the turnaround time is to actual production of those kinds of systems and if anything has happened in the quarter since in terms of design win pace and/or getting to production on some of those design wins?

We are happy with the response to our sensors. There has been significant attention on rare earth magnets and materials like neodymium and dysprosium, which are primarily sourced from China and have concerning supply chains and tariff risks. Therefore, we have long provided rare earth-free magnets as well as high-sensitivity sensors to detect them. We actively promote these products at every trade show, and we have interested customers who mention that they can effectively use regular ferrite magnets on advanced sensor systems, which they indeed can. I believe this has already led to some sales. While it is hard to quantify how many of these sales involve replacing rare earth magnets, I am confident that a portion of them does.

Dan, this is Pete Previte down in Florida. I'm sorry, I wasn't able to make the shareholder meeting this year, but I'm going to try to get there next year. I was excited to hear about the progress you made over the last year. I remember touring and you guys are doing a little demo of the East side, and it sounds like you've got that all set up and you got your equipment going. Can you talk a little bit about space? I know space is a premium there, and you were looking at maybe additional buildings for future expansion? What's the situation with the space that you have there?

Well, Pete and his team did a fabulous job of freeing up the space that you saw. Of course, you saw it unfinished when you were here a little more than a year ago, and it's packed right now. But it's working for us. We renewed our lease in order to make it economically viable to expand in this building, and we have additional plans to expand if need be. So we think this building will hold us, and we also have contingency plans that we hope to be able to execute that would involve moving certain groups into a different building in order to expand our production and other areas. So we have a plan, and it didn't involve having to move a lot of equipment from our current building, which would have been expensive and potentially disruptive.

Okay. That's great to hear. And it's great about to hear about the new products certainly getting into the robotic market. Can you talk a little bit about, is there any potential in the future? I know it might be a little bit lower margin, but are you able to potentially target the Hall Effect sensor market at any point where maybe your price at your cost structure can be reduced where you can be more competitive? Or is that just not a target market at all?

The high end of that market is a target market. So for folks unfamiliar, Hall Effect is a type of semiconductor magnetic switch. We make spintronic non-semiconductor switches. So we have a number of advantages that we've talked about repeatedly in terms of the small size, the high reliability, the low power and the ability to provide smart connections for sophisticated systems. But it's not our goal to compete with commodity switches. But we talked about, for example, Jeff brought up the gaming market, which is a high-end market that's currently Hall Effect Sensors. And if there is a need for folks who have reaction times in the microseconds rather than milliseconds, we believe that that's the type of market that perhaps we could look at. And there are other types of markets like that, where they're using Hall Effect Sensors now and they can improve the performance significantly using our sensors. Where there are — the markets where Hall Effect Sensor is good enough and they're really cheap versions. Those are not markets that we would typically target.

Great. And I think there was an announcement today by Amazon where they want to start replacing a lot of people in their distribution centers with robots. Are those the types of robotic applications where NVE parts would potentially be used?

They are. Those are the types of industrial robots, the Industrial Internet of Things and the artificial intelligence of things that are the markets where we have a great benefit proposition. So smart factories, smart warehouses where they need sensor inputs and they need precision and speed. That's where we can add a lot of value. So those are the types of markets that we are targeting.

Dan, this is Mike Ostermeyer.

Hi, Mike.

Quick, I think, I believe a couple of calls back, you folks were thinking of breaking out your product sales by segments, defense, in particular, is my memory correct on that in your reports?

Well, we don't break out segments. We do try to give some additional context and color on these calls, which Daniel did. And so this was a quarter where our underlying core business, the nondefense business was extremely strong. So we wanted to provide that level of detail to you, our investors. So we'll continue to do that. Formally putting it into reports and things, that's a little bit tougher.

Okay. The other question is what percentage of your sales comes from distributors versus direct sales, considering that distributor sales have lower margins.

We don't have exact percentages, but both distributor and direct sales are significant to us. Direct sales typically target larger customers in specific markets like medical devices, while distributor sales reach a broad range of customers and generally involve smaller order volumes. We view both channels as important, but the distributor market is distinctive due to the substantial inventory they carry, which adds value. During industry downturns, as seen a couple of years ago, distributor sales tend to decline as they work to reduce their inventories. We are pleased to see the recovery in distributor sales that Daniel mentioned in the prepared remarks.

Okay. So that tends to be somewhat of a roller coaster, possibly due to the industry and the macro background. And then I have one other thing. Is there an issue? In the past, I used to receive emails about the conference calls, but for some reason, that has suddenly stopped. I'm also having problems sending out reports.

No, not that I know of, but I will — our IT team is here, and they were making notes to make sure that you get your e-mails.

Okay. Because I mean I knew it was coming, but I saw it through other newer sites...

Okay. We'll check on that. But we know who you are, Mike, and we'll keep you informed.

Dan, this is Don Ger. I'm a co-founder and retired CIO of a large wealth management firm. I'm just curious, looking through the past reports on the contract R&D, it's been really lumpy over time. But kind of looking through the expense ratio you're dropping a good part of that to the bottom line, it looks like. Could you just give a little bit of color on your approach to contract R&D, the amount of time that it takes and maybe takes away from other projects along the way?

Right. So contract R&D tends to be mostly defense-related and can be, as you say, lumpy and cyclical. But we view it primarily as a way to facilitate future sales and build our intellectual property portfolio. So particularly for government or government-sponsored R&D contracts, we typically own the resultant intellectual property. So it's a way to build our intellectual property portfolio without a direct expense hitting the bottom line because as you implied in the case of contract R&D, the expenses associated with that R&D are considered cost of sales, and so we make a profit on — generally on contract R&D. It's not the main reason we do it. The main reason we do it is to develop new products where we have potential customers, particularly in the Defense segment, and to build our intellectual property portfolio. But we consider our R&D team extremely valuable. So we look at that and we look at balancing the opportunity cost of deploying valuable resources on contracts versus in-house R&D. And so that pet mix can change depending on contracts available and our internal opportunities.

Okay. So basically, they're subsidizing your internal R&D growth taking away from some of the other expenses you might have incurred, and they're using it as a stocking horse for future sales. As you go into periods such as we're in right now with the government shutdown, is that affecting the upcoming months and the current period of time? Or are you structured that the contract is in place and it just keeps rolling over like an annuity?

Yes, I can address that, Don. The shutdown is probably going to be much shorter term than the typical cycles for contract R&D work. So we're not too concerned about what looks to be a relatively prolonged shutdown.

And so you're expecting a bounce back in the current quarter? Or are we kind of flattening out on a quarter-by-quarter basis or quarter-over-quarter basis?

Well, our goal is always to grow. And I think we feel fairly confident that we can grow in the current quarter. Now that's the December quarter. And part of that is because, frankly, last year was a little easier to compare than we sometimes have. But also, we're — we feel that we have a good pipeline in most areas of our business, and the industry has recovered. So we're very optimistic about the future and certainly the long-term prospects for growth, we're very optimistic.

Okay. And the reason I was asking is it looks like any type of bounce back or had you not seen that 1/3 basically on a comparison basis year-over-year. your drop in earnings was pretty much coming from that segment. So looking into the next quarter or so, any sort of bounce back should be positive on a sequential basis to help the underlying earnings.

Yes.

And then just one kind of a little bit off-the-wall question, but looking at the interest income, which went up year-over-year despite, I believe, cash coming down overall, your marketable securities and cash and when you add them all together, at least if I did it properly, we're in a period of declining rates. Did you extend your portfolios?

So this is Daniel here, Don. So the increase in interest income in the past quarter is primarily due to the new security purchases, and those securities were purchased at higher interest rates than the ones that matured in the prior year quarter. And the decrease in our cash and cash equivalents is primarily because we paid more in cash dividends than we generated in cash flows from operations.

Well, we're about out of time. We appreciate — was there one more question?

There is, if it's open. It's Chip Really at Rui Asset Management. I appreciate the discussion on the contract R&D. And just following up on that to confirm that doesn't really have any correlation with product revenue growth over the next year or so, it's really targeted just to the DoD? And that's one question. The second question would be, clearly, the medical and sensor and robotic markets are great, but you've mentioned a couple of times the defense market is not a target market for you. Just curious on your thinking on that. If I heard that correctly, and kind of what are your thoughts? It seems to be there's a lot of spending in areas that it seems you could take advantage of there. So just kind of those 2 clarifying questions.

Yes. Thank you for the question. So on your first question, most of contract R&D, as we said in the prepared remarks, is defense related. So the other part of your question is that we do consider defense an important part of our business, and we seek those contracts and those product sales. However, we don't see it as part of our long-term growth engine. It's not a fast-growing market. But we believe that it also indirectly, as I alluded to in one of the prior questions, it indirectly helps our long-term product sales by building our intellectual property portfolio in a number of areas, some of which have commercial applications for larger markets. In terms of the defense contracts relating to defense products, that can be — sometimes we'll finish an R&D contract. And if it's successful, and Pete and his team do a great job, it usually is. Then there's often product sales that are tied to that contract. So it's not always blue sky research or long-term research as one might say. It can be targeted research at a particular problem. And if we can come up with solutions to that problem, we can sell products relatively near-term.